title: [Hypertension in pregnancy: proposed monitoring and therapy].
authors.forename: C
authors.initials: C
authors.lastname: Durando
authors.forename: L
authors.initials: L
authors.lastname: Leidi
authors.forename: E
authors.initials: E
authors.lastname: Margaria
authors.forename: M
authors.initials: M
authors.lastname: Medaglia
authors.forename: M
authors.initials: M
authors.lastname: Gessa
authors.forename: G
authors.initials: G
authors.lastname: Maina
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000009:adverse effects / Q000627:therapeutic use; D002216:Captopril / Q000627:therapeutic use; D004232:Diuretics / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006830:Hydralazine / Q000627:therapeutic use; D006973:Hypertension / Q000188:drug therapy*; D007741:Labetalol / Q000627:therapeutic use; D008750:Methyldopa / Q000627:therapeutic use; D011224:Prazosin / Q000627:therapeutic use; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000188:drug therapy*
chemical_list: D000319:Adrenergic beta-Antagonists; D004232:Diuretics; D006830:Hydralazine; D008750:Methyldopa; D002216:Captopril; D007741:Labetalol; D011224:Prazosin
vernacular_title: L'ipertensione in gravidanza: proposte di monitoraggio e terapia.